The Red Balloon Release, is a nationally coordinated event that is scheduled on Wednesday, February 22, 2012 and will take place concurrently around the nation at 1PM EST, 12 PM CST, 11 AM MST and 10 AM PST.
Pittsburgh, PA (PRWEB) February 21, 2012
The International EECP® Therapists Association (“IETA”), announced today that EECP Therapy Week got off to a great start this week with a number of EECP® centers around the country holding special events in recognition of American Heart Month. The week of February 20th – 24th, 2012 was introduced as the first annual “EECP® Therapy Week” by the IETA to increase public awareness of EECP® therapy, an FDA cleared, noninvasive therapy for angina and congestive heart failure.
The special events in support of EECP® week being held around the country include, wear red fashion shows sponsored by EECP® centers in their children’s schools, wearing red to work, patient receptions, daily lectures all week on heart healthy foods/exercise/supplements, free blood pressure screenings, free evaluation interviews for EECP® and a coordinated Red Balloon Release.
The Red Balloon Release, is a nationally coordinated event that is scheduled on Wednesday, February 22, 2012 and will take place concurrently around the nation at 1PM EST, 12 PM CST, 11 AM MST and 10 AM PST. The Red Balloon Release is a unique and highly visible activity that will bring EECP® staff and patients together to send a special “red” message to the sky as a tribute by patients to the effects that EECP® therapy has had on their health and the quality of their lives. This eco-friendly event will use biodegradable red latex balloons, tied by hand and released without strings, ribbons or plastic ties. The Red Balloon Release is slated to take place on Wednesday, February 22 and will take place concurrently around the nation at 1PM EST, 12 PM CST, 11 AM MST and 10 AM PST.
The IETA was established in 2000 by a group of dedicated EECP® therapists and supervisors to share their collective knowledge and experience in providing EECP® therapy, a relatively new technology at the time, in order to ensure the highest possible patient benefits and safety, as well as increase the operational success of their centers. IETA membership has grown over the past 12 years both in the U.S. and overseas. Both U.S. Medical Director, Dr. Joseph Tartaglia and Dr. Subramanian Ramasamy, the International Medical Director, have been involved in providing EECP® therapy to patients for over 15 years and been involved in controlled clinical trials demonstrating the safety and efficacy of EECP® therapy that have been published in peer reviewed medical journals.